title: Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.
authors.affiliation: Bone Marrow Transplant Unit, Division of Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy. torelli@bce.uniroma1.it
authors.forename: Giovanni F
authors.initials: GF
authors.lastname: Torelli
authors.forename: Fiammetta
authors.initials: F
authors.lastname: Natalino
authors.forename: Walter
authors.initials: W
authors.lastname: Barberi
authors.forename: Anna P
authors.initials: AP
authors.lastname: Iori
authors.forename: Chiara
authors.initials: C
authors.lastname: Andreoli
authors.forename: Veronica
authors.initials: V
authors.lastname: Valle
authors.forename: Caterina
authors.initials: C
authors.lastname: Mercanti
authors.forename: Salvatore
authors.initials: S
authors.lastname: Perrone
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Gualdi
authors.forename: Robin
authors.initials: R
authors.lastname: Foà
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007262:Infusions, Intravenous; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D019653:Myeloablative Agonists / Q000008:administration & dosage; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists; D016572:Cyclosporine